logo
Top Stories
56
45
strestest-june22-lg.jpg

The Federal Reserve has determined that the largest U.S. banks are strongly capitalized and would be able to lend to banks as well as households during a severe global economic recession. This is the fourth straight year that all banks have met the Federal...

eurozone-june22-lg.jpg

Eurozone private sector regained some momentum in June fueled by an improved service sector performance, while the pace of growth in manufacturing activity waned. The composite output index rose unexpectedly to 54.8 in June from 54.1 in May, flash...

donald-trump2-062218-lg.jpg

In a move likely to further inflame global trade tensions, President Donald Trump has threatened to impose a 20 percent tariff on all cars imported to the U.S. from the European Union. Trump stated in a post on Twitter on Friday that he would impose...

wallstreet-111914_22jun18.jpg

Stocks are mostly higher in mid-day trading on Friday, although the tech-heavy Nasdaq continues to linger modestly below the unchanged line. The Dow is attempting to avoid its longest losing streak in over forty years.

martinscorsese-june20-lg.jpg

Cinema Foundation for Rome (Fondazione Cinema per Roma) will confer veteran U.S. film maker Martin Scorsese with the Lifetime Achievement Award at the Rome Film Fest. The award was announced jointly by director Antonio Monda and Laura Delli Colli,...

wallstreet-112014_15jun18.jpg After coming under pressure early in the session, stocks regained some ground over the course of the trading day on Friday. The major averages climbed well off their lows of the session, with the S&P 500 briefly turning positive.
pharma-june15.jpg The week that went by saw NASH drug stocks back in focus as positive results from a phase II study of Galmed Pharmaceuticals Ltd.'s (GLMD) investigational drug Aramchol seems to have had a positive rub off impact. Aramchol is being developed for treatment of patients with biopsy proven non-alcoholic steatohepatitis, or NASH.
asian-market-100912_17jun18.jpg Asian stock markets are in negative territory on Monday amid an escalation in trade tensions between the U.S. and China after the world's two largest economies announced tit-for-tat trade tariffs last week. In addition, weak commodity prices weighed on resources stocks. Crude oil prices extended losses in Asian trading after falling sharply on Friday.
asian-markets2_18jun18.jpg European stocks may follow Wall Street and Asia lower on Monday as renewed concerns over a global trade war dented investors' appetite for risk. Asian markets drifted lower in cautious trade as the trade spat escalated between the world's top two economies....
Read More
donald-trump2-062218.jpg In a move likely to further inflame global trade tensions, President Donald Trump has threatened to impose a 20 percent tariff on all cars imported to the U.S. from the European Union. Trump claimed he would impose the new tariffs unless the EU removes tariffs and trade barriers placed on the U.S.
Read More
bobgoodlatte-062118.jpg In a widely expected move, the House voted against immigration reform legislation seen as the more conservative of two separate bills expected to be voted on this week. The House voted 231 to 193 against the bill known as the Securing America's Future Act on Thursday.
Read More
eurozone-june22.jpgEurozone private sector regained some momentum in June fueled by an improved service sector performance, while the pace of growth in manufacturing activity waned. The composite output index rose unexpectedly to 54.8 in June from 54.1 in May, flash data from IHS Markit showed Friday. The score was forecast to fall to 53.9.
Read More
One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More
geceo-june22.jpg
A 30-year GE veteran, top man Flannery is no run-of-the-mill guy. When he assumed leadership of the struggling GE Healthcare business in 2014, the general consensus was he would spin-off or sell the segment, but he did neither. Today, Healthcare is one of the strongest arms of GE, and a notable player in the production of cell therapies and biologics - the cutting-edge of biomedical research.
Read More
Bitcoin and its peers had a sluggish start to the week after sentiment was hurt by a bleak view on cryptocurrencies by the Basel-based central bank of central banks, but they recovered mid-week despite more negative news in the form of a hack of a major crypto exchange in South Korea. However, cryptocurrencies are likely set for a weak closing to the week as they were deep in the red Friday. Read More
Today's Daily Dose brings you news about Atossa's progress in phase I study of its proprietary topical Endoxifen in men; the three biopharmaceutical companies that are set to debut on the Nasdaq on June 21, 2018; Kindred Biosciences' financial position; FDA panel review date of Paratek's Omadacycline NDA, and STAAR Surgical's resolution of FDA warning letter. Read More
The following are some of the stocks that gained the largest percentage in price today in the pharma/biotech sector. Read More
ey-june22.jpg EY and Microsoft joined together to launch a blockchain solution for content rights and royalties management in the gaming industry. The move aims to streamline the costly and time-consuming processes, by reducing processing time and faster tracking of royalties.
Read More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
06/22/18 13:0Baker Hughes - Rig CountJUN 22 United States
06/22/18 9:45PMI ManufacturingJUN P United States
06/22/18 9:45PMI CompositeJUN P United States
06/22/18 9:45PMI ServicesJUN P United States
06/22/18 9:0Business SentimentJUN Belgium
06/22/18 9:0CB Coincidence IndexMAY India
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
09/16/18TEVAFremanezumab (BLA)FDA decision on Fremanezumab for the treatment of migraine
09/05/18RHHBYTECENTRIQ (sBLA)FDA decision on TECENTRIQ in combination with Avastin or bevacizumab, paclitaxel and carboplatin or chemotherapy for initial treatment of people with metastatic NSCLC
09/03/18ADMPSymjepi (sNDA)FDA decision on low dose Symjepi (0.15mg) for the emergency treatment of anaphylaxis
08/30/18AKCAVolanesorsen (NDA)FDA decision on Volanesorsen for the treatment of familial chylomicronemia syndrome (FCS).
08/28/18TTPHEravacycline (NDA) FDA decision on Eravacycline for the treatment of complicated intra-abdominal infections
View All